CGT 360

Business management and consulting services for the health care industry, namely, business management of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies for health plans, health insurers, self-funded plans, and reinsurers; Business management and administration in the field of healthcare, namely, development, creation and implementation of health care provider networks in the field of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Business administration of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapy programs; Business data analytics services, namely, health data collection and analysis in the nature of data compiling and analyzing to provide information and metrics regarding health insurance claims to help clients forecast outcomes, business risk, and expenses; Data acquisition and collection for insurance services for business purposes; Business research in the field of health care relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapy programs; Medical cost management relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies.

Financial consultation to healthcare providers, namely, providing assistance in managing health care expenses related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Group financial risk management services, namely, health care expense risk pooling and financial risk management services related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing financial and insurance information and consulting in the fields of insurance and healthcare preferred provider networks relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; preferred provider network programs, namely, administration of medical services in the nature of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies provided through a network of health care providers; Preferred provider network services, namely, administering medical benefits in the nature of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies provided through a network of health care providers under an insurance plan

Consulting services in the field of medical care, namely, developing medical treatment policies related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing medical information in the field of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Concierge medical services, namely, personal health care concierge services to guide patients through medical treatments related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Medical consultations, namely, consulting, advising, and assisting patients and families with navigating the complex healthcare system relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing information in the field of health care, namely, models of care, medical practice, and health care delivery and outcomes, all relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Healthcare services, namely, provision of medical care related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies provided by a network of providers through an integrated, coordinated model of care delivery, with communication of best practices among the network, and the sharing of quality metrics with participants in the network; Consulting regarding healthcare services provided through an integrated and comprehensive model of care delivery featuring protocols, standards, staff training and education, implementation measures for management, care coordination, and disease management all in the field of cell and gene therapy, solid organ and bone marrow transplants, and other complex medical therapies